Global Biochip Market 2017-2021

バイオチップの世界市場2017-2021:マイクロアレイ、マイクロ流体

◆タイトル:Global Biochip Market 2017-2021
◆商品コード:IRTNTR14503
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年8月22日
◆ページ数:79
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

TechNavioが出版した当調査レポートでは、バイオチップの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、バイオチップの世界市場規模及び予測、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社はバイオチップの世界市場が2017-2021年期間中に年平均17.53%成長すると予測しています。当レポート上に記載されている主な企業は• Abbott• Agilent Technologies • Illumina • PerkinElmer• Thermo Fisher Scientific等です。

About Biochip
Biochips are bio-microsystems. Bio-microsystems are small integrated devices used for biochemical reactions, biological monitoring, research, academic studies, drug discovery, and much more. In simple terms, biochips are small sized chips that can perform multiple (generally thousands) biochemical reactions parallelly. A collection of microarrays or micro-test sites form these biochips. Microarrays when arranged on a surface made up of either glass or silicon, can perform large numbers of tests at the same. Thus, they help in cost and time saving.

Technavio’s analysts forecast the global biochip market to grow at a CAGR of 17.53% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global biochip market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• APAC
• Europe
• North America
• ROW

Technavio’s report, Global Biochip Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott
• Agilent Technologies
• Illumina
• PerkinElmer
• Thermo Fisher Scientific

[Other prominent vendors]
• BioChain
• Bio-Rad Laboratories
• Cepheid
• EMD Millipore
• Fluidigm
• SuperBioChips Laboratories
• US Biomax

[Market driver]
• Increase in market presence with collaboration strategy
• For a full, detailed list, view our report

[Market challenge]
• Standardization and accuracy issues
• For a full, detailed list, view our report

[Market trend]
• Growth in bioinformatics software industry
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline
• Market size and forecast
• Five forces analysis

PART 05: Market segmentation by fabrication technology
• Global biochip market by microarrays
• Global biochip market by microfluidics

PART 06: Geographical segmentation
• Biochip market in Americas
• Biochip market in EMEA
• Biochip market in APAC

PART 07: Decision framework

PART 08: Drivers and challenges
• Market drivers
• Market challenges

PART 09: Market trends
• Increasing POC diagnostics
• Growing application of biochips in pharmacogenomics
• Rise in vendors’ strategic initiatives
• Increasing use of biochip technology as alternative to animal testing

PART 10: Vendor landscape
• Competitive scenario
• Investment opportunity

PART 11: Key vendor analysis
• Agilent Technologies
• GE Healthcare
• PerkinElmer
• Thermo Fisher Scientific
• Other prominent vendors

PART 12: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Types of biochips and their applications
Exhibit 02: The biochip platform
Exhibit 03: Global biochip market: Overview
Exhibit 04: Global biochip market 2016-2021 ($ billions)
Exhibit 05: Significance of biochip in different sectors
Exhibit 06: Factors impacting global biochip market
Exhibit 07: Five forces analysis
Exhibit 08: Global biochip market by fabrication technology 2016-2021 (% share)
Exhibit 09: Global biochip market by fabrication technology: Snapshot
Exhibit 10: Global biochip market by microarrays 2016-2021 ($ billions)
Exhibit 11: Applications of DNA microarrays
Exhibit 12: Global biochip market by microfluidics 2016-2021 ($ billions)
Exhibit 13: Applications of lab-on-a-chip
Exhibit 14: Global biochip market by geography 2016-2021 (% share)
Exhibit 15: Global biochip market by geography: Snapshot
Exhibit 16: Growth perspective in developed and developing market
Exhibit 17: Biochip market in Americas 2016-2021 ($ billions)
Exhibit 18: Programs held by companies in global biochip market
Exhibit 19: Biochip market in EMEA 2016-2021 ($ billions)
Exhibit 20: Biochip market in APAC 2016-2021 ($ billions)
Exhibit 21: Biochips in testing agriculture products
Exhibit 22: Major chronic disease-related deaths 2012 (in thousands)
Exhibit 23: Strategic success factors for vendors
Exhibit 24: Investment opportunity mapping
Exhibit 25: Agilent Technologies: Profile
Exhibit 26: Agilent Technologies: Strength analysis
Exhibit 27: Agilent Technologies: Strategy assessment
Exhibit 28: Agilent Technologies: Opportunity assessment
Exhibit 29: GE Healthcare: Profile
Exhibit 30: GE Healthcare: Strength analysis
Exhibit 31: GE Healthcare: Strategy assessment
Exhibit 32: GE Healthcare: Opportunity assessment
Exhibit 33: PerkinElmer: Profile
Exhibit 34: PerkinElmer: Strength analysis
Exhibit 35: PerkinElmer: Strategy assessment
Exhibit 36: PerkinElmer: Opportunity assessment
Exhibit 37: Thermo Fisher Scientific: Profile
Exhibit 38: Thermo Fisher Scientific: Strength analysis
Exhibit 39: Thermo Fisher Scientific: Strategy assessment
Exhibit 40: Thermo Fisher Scientific: Opportunity assessment



【掲載企業】

Abbott, Agilent Technologies, Illumina, PerkinElmer, Thermo Fisher Scientific, BioChain, Bio-Rad Laboratories, Cepheid, EMD Millipore, Fluidigm, SuperBioChips Laboratories, and US Biomax.


【資料のキーワード】

バイオチップ、マイクロアレイ、マイクロ流体

★調査レポート[バイオチップの世界市場2017-2021:マイクロアレイ、マイクロ流体] (Global Biochip Market 2017-2021 / IRTNTR14503)販売に関する免責事項
[バイオチップの世界市場2017-2021:マイクロアレイ、マイクロ流体] (Global Biochip Market 2017-2021 / IRTNTR14503)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆